Catalyst Biosciences, Inc.

NasdaqCM:CBIO Stock Report

Market Cap: US$19.4m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Catalyst Biosciences Dividends and Buybacks

Dividend criteria checks 0/6

Catalyst Biosciences does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.1%

Buyback Yield

Total Shareholder Yield-0.1%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

Catalyst Biosciences declares special one-time dividend of $1.43

Aug 25

Catalyst Biosciences: Shareholders Should Reap Benefits From Owning The Stock

Aug 15

Catalyst Biosciences plans to distribute $65M cash to stockholders

Jun 29

Companies Like Catalyst Biosciences (NASDAQ:CBIO) Could Be Quite Risky

Jan 11
Companies Like Catalyst Biosciences (NASDAQ:CBIO) Could Be Quite Risky

Circling Back On Catalyst Biosciences

Dec 08

Shareholders May Not Be So Generous With Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Compensation And Here's Why

Jun 03
Shareholders May Not Be So Generous With Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Compensation And Here's Why

Catalyst Biosciences (NASDAQ:CBIO) Will Have To Spend Its Cash Wisely

May 18
Catalyst Biosciences (NASDAQ:CBIO) Will Have To Spend Its Cash Wisely

Catalyst Biosciences EPS misses by $0.12, beats on revenue

May 06

Would Shareholders Who Purchased Catalyst Biosciences' (NASDAQ:CBIO) Stock Five Years Be Happy With The Share price Today?

Mar 09
Would Shareholders Who Purchased Catalyst Biosciences' (NASDAQ:CBIO) Stock Five Years Be Happy With The Share price Today?

We're Hopeful That Catalyst Biosciences (NASDAQ:CBIO) Will Use Its Cash Wisely

Feb 01
We're Hopeful That Catalyst Biosciences (NASDAQ:CBIO) Will Use Its Cash Wisely

Catalyst Biosciences announces closing of $50M capital raise

Jan 29

Do Institutions Own Catalyst Biosciences, Inc. (NASDAQ:CBIO) Shares?

Dec 28
Do Institutions Own Catalyst Biosciences, Inc. (NASDAQ:CBIO) Shares?

Catalyst Biosciences' MarzAA fast track'd for episodic bleeding in hemophilia patients

Dec 02

What We Learned About Catalyst Biosciences' (NASDAQ:CBIO) CEO Pay

Dec 02
What We Learned About Catalyst Biosciences' (NASDAQ:CBIO) CEO Pay

Catalyst Biosciences (CBIO) Presents At Stifel 2020 Virtual Healthcare Conference - Slideshow

Nov 18

Catalyst Biosciences: After 2 Fundraisings, A Lengthy Wait For Pivotal Trial Data Is Next

Nov 14

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CBIO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CBIO's dividend payments have been increasing.

Dividend Yield vs Market

Catalyst Biosciences Dividend Yield vs Market
How does CBIO dividend yield compare to the market?
SegmentDividend Yield
Company (CBIO)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.4%
Industry Average (Biotechs)1.7%
Analyst forecast (CBIO) (up to 3 years)n/a

Notable Dividend: Unable to evaluate CBIO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CBIO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate CBIO's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CBIO has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/31 06:37
End of Day Share Price 2023/10/30 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Catalyst Biosciences, Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
George ZavoicoB. Riley Securities, Inc.
Gbolahan Amusa BenzChardan Capital Markets, LLC
Kevin DeGeeterLadenburg Thalmann & Company